Global Radiotherapy Market worth $5.8 bn by 2016

Thursday 12 July 2012, Amsterdam

The "Radiotherapy Devices Market By Technology, Applications & Products (2011 - 2016) " , analyzes and studies the major market drivers, restraints, and opportunities in Americas, Europe, Asia, and Rest of the World including Japan.

This report studies the global radiotherapy devices market over the forecast period 2011-2016.

Radiation therapy is one of the advanced treatment and diagnostic procedures to kill damaged cells using focused energy with an intension to limiting harmful effects to the neighbouring healthy cells. Radiotherapy is generally applied either alone or along with the combination of surgery or chemotherapy. The major driving force in the advancements in radiation oncology over the conventional radiotherapy is the unique therapeutic effect on genetic materials of damaged cells. Radiotherapy interrupts cell replication and causes the cell-death eventually.

The global radiotherapy devices market is classified into external radiotherapy, internal radiotherapy (brachytherapy) and systemic radiotherapy. The radiation therapy market is expected to grow at a faster rate with a CAGR of 5.3% from 2011 to 2016.

The global radiotherapy market has seen challenging and dynamic market conditions, but still remains strong, with a size of approximately $4.4 bn in 2011, at an estimated annual growth rate of 5.3% over the next five years. A large number of technological innovations in the devices used in such procedures have been seen in the past years, with newer devices coming up with better safety and efficacy attributes contributing to widespread adoption of the radiotherapy procedures by physicians worldwide.

The worldwide market for radiotherapy devices is principally commanded by major players, such as Varian Medical System, Accuray, Inc., Elekta AB, IsoRay Medical, Inc. etc.